FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older
SILBERFEDER, Md., February 5, 2021 / PRNewswire / – Today the US Food and Drug Administration cleared the commercialization of
Read More